Last reviewed · How we verify
intracoronary infusion,
The intracoronary infusion, developed by Istanbul University, is currently marketed but lacks detailed information on its mechanism, primary indication, and revenue. A key strength is the protection offered by the composition patent, which expires in 2028. The primary risk is the lack of clear competitive positioning and trial results, which may affect market adoption and investor confidence.
At a glance
| Generic name | intracoronary infusion, |
|---|---|
| Also known as | Streptase |
| Sponsor | Istanbul University |
| Modality | Small molecule |
| Phase | FDA-approved |
Approved indications
Common side effects
Key clinical trials
- Postprocedural Contrast Mediated FFR Plus Intracoronary Infusion of Nitroglycerin in Multivessel Patients (PROMETEUS TRIAL) (NA)
- Artificial Intelligence-Driven Medipixel Fractional Flow Reserve Versus Invasive Fractional Flow Reserve-Guided PCI Trial (AIM-FFR Trial) (NA)
- Assessing the Safety and Effectiveness of Intracoronary Stem Cells in Patients With Refractory Angina (PHASE2)
- Intracoronary Hypothermia as a Prevention of Reperfusion Injury in Myocardial Infarction. (NA)
- Phosphatase Inhibition by Intracoronary Gene Therapy in Subjects With Non-Ischemic NYHA Class III Heart Failure (PHASE2)
- Efficacy and Safety of Zotarolimus-eluting Stent Overexpansion With OCT
- Safety Evaluation of Intracoronary Infusion of Extracellular Vesicles in Patients Following Coronary Stent Implantation (PHASE1)
- : Vascular Function in Health and Disease (PHASE1)
Primary sources
Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.
| Source | Used for |
|---|---|
| ClinicalTrials.gov | Trial enrolment, design, endpoints, results |
Competitive intelligence
For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:
- intracoronary infusion, CI brief — competitive landscape report
- intracoronary infusion, updates RSS · CI watch RSS
- Istanbul University portfolio CI